Stocktoria

SpyGlass Pharma, Inc. SGP

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2026-02-06

SpyGlass Pharma, Inc. statistics & valuation

Market cap$708.1M
Return on capital-38.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
20242025
Shares outstanding
2.2M 2.2M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-125.10% -34.40% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$16.31 -$17.98 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-34.4%-125.1%
Return on equity40.3%48.2%
Current ratio12.672.23

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.